CVS PHARMACY TO STRENGTHEN POLICIES AROUND DISPENSING OPIOIDS AND REQUIRE USE OF PRESCRIPTION MONITO
FOR IMMEDIATE RELEASE MEDIA CONTACT:
September 1, 2016 Emalie Gainey
CVS PHARMACY TO STRENGTHEN POLICIES AROUND DISPENSING OPIOIDS AND REQUIRE USE OF PRESCRIPTION MONITORING PROGRAM IN GROUNDBREAKING SETTLEMENT
Pharmacy Chain to Pay Total of $795,000; AG’s Office to Direct $500,000 of Settlement to Address Opioid Dependence and Addiction
BOSTON – In a first-in-the-nation settlement with the largest pharmacy chain in the country, Attorney General Maura Healey announced today that CVS Pharmacy, Inc. (CVS) will strengthen its policies and procedures around the dispensing of opioids and will require its Massachusetts pharmacy staff to check the state’s Prescription Monitoring Program before filling prescriptions for commonly misused opioids.
The assurance of discontinuance, filed today in Suffolk Superior Court, along with a separate settlement agreement between CVS and AG Healey’s Office, resolves allegations that CVS failed to provide its Massachusetts pharmacists with a way to access the Massachusetts Online Prescription Monitoring Program (PMP) prior to March 2013. The PMP provides the prescription history of a patient that can help identify drug-seeking behavior.
The assurance and settlement agreement also resolve allegations that certain CVS pharmacies in Massachusetts failed to monitor drug use patterns or use sound professional judgment when dispensing controlled substances, particularly opioids.